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Abstract
The synthesis of quaternary ammonium (QA)-functionalized silica nanoparticles with and without
nitric oxide (NO) release capabilities is described. Glycidyltrialkylammonium chlorides of varied
alkyl chain lengths (i.e., methyl, butyl, octyl, and dodecyl) were tethered to the surface of amine-
containing silica nanoparticles via a ring-opening reaction. Secondary amines throughout the
particle were then functionalized with N-diazeniumdiolates NO donors to yield dual functional
nanomaterials with surface QAs and total NO payloads of ca. 0.3 μmol/mg. The bactericidal
activities of singly (i.e., only NO-releasing or only QA-functionalized) and dual (i.e., NO-
releasing and QA-functionalized) functional nanoparticles were tested against Grampositive
Staphylococcus aureus and Gram-negative Pseudomonas aeruginosa. Particles with only NO
release capabilities alone were found to be more effective against P. aeruginosa, while particles
with only QA-functionalities exhibited greater toxicity toward S. aureus. The minimum
bactericidal concentrations (MBC) of QA-functionalized particles decreased with increasing alkyl
chain length against both microbes tested. Combining NO release and QA-functionalities on the
same particle resulted in an increase in bactericidal efficacy against S. aureus; however, no change
in activity against P. aeruginosa was observed compared to NO-releasing particles alone.
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INTRODUCTION
With increasing occurrences of microbial antibiotic resistance,1 alternative approaches for
fighting infections have become necessary. Co-administering two antimicrobials that act via
different mechanisms has been shown to significantly reduce microbial resistance and often
results in synergy where the two agents are more effective in combination than when
administered alone.2, 3 As such, researchers are developing strategies to modify
macromolecules (e.g., dendrimers, particles, polymers) with multiple antimicrobial
agents.4-6 For example, macromolecular vehicles have been designed to consist of a
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permanent antimicrobial characteristic that remains after the depletion of the releasable
agent.7
Long chain quaternary ammoniums (QA) are a popular non-depleting antimicrobial
component due to their broad-spectrum efficacy, simple structure, and ability to kill bacteria
with no affect on the QA structure.8 The positively charged ammonium group promotes
direct interaction with the negatively charged bacterial membrane, causing chemical
imbalances by replacing essential metal cations. Simultaneously, the long alkyl chain of
QAs inserts into the membrane and cause physical damage. The simple structure of the QA
functionalities allows for straight forward integration into polymers,9, 10 films,11-13
dendrimers,14 and particles,8, 15, 16 while still retaining their antimicrobial properties.
Unfortunately, tethering QAs to polymers or particles limits their action to only those
bacteria that come in direct contact with the macromolecule. Thus, coupling QA
functionalities with a second releasable agent may increase the materials’ sphere of
influence and benefits from the advantages of the combination therapies discussed above.
Indeed, QA-functionalized polymers impregnated with releasable silver ions (Ag+) exhibited
a wider zone of inhibition than QA polymers alone.7, 17 Similarly, Wong et al. reported
improved efficacy of QA-functionalized layer-by-layer coatings that leached gentamicin
against biofilm formation.18
To date, most combination strategies have only been applied to polymeric coatings or films.
Silica nanoparticles are well-poised for combination therapies due to their high surface area
to volume ratio, chemical flexibility, and limited toxicity to mammalian cells.19 Our
laboratory has demonstrated the broad-spectrum bactericidal efficacy of silica nanoparticles
that actively release nitric oxide (NO),20-22 a gaseous molecule produced endogenously as
part of the innate immune response.23 Nitric oxide and its reactive byproducts decrease
bacterial viability via both lipid peroxidation and reaction with membrane proteins, DNA,
and metabolic enzymes.23 The key advantage of employing NO over other releasable agents
(e.g., silver and antibiotics) involves NO’s multimodal antimicrobial activity and low
toxicity to mammalian cells at concentrations necessary for antimicrobial action.24
Furthermore, initial studies suggest the inability of bacteria to develop resistance to
nanoparticle derived NO.25 The potential of NO-based therapeutics is evident in the
immense research efforts focused on designing NO-releasing macromolecular vehicles for
biomedical applications. 26,27
The storage of exogenous NO within silica nanoparticles is achieved by forming N-
diazeniumdiolate NO donors on secondary amine sites incorporated within the silica
network (Scheme 1).22, 28 Upon exposure to physiological solution (pH 7.4, 37 °C), the N-
diazeniumdiolates undergo proton-initiated decomposition to release two molecules of NO
per secondary amine site. Moreover, the rate of NO release is dependent on the NO donor
structure and chemical environment. We hypothesize that the incorporation of long chain
quaternary ammoniums onto the surface of NO-releasing silica nanoparticles may result in
increased efficacy compared to singly functionalized particles (i.e., QA or NO release
alone). Herein, we investigated the role of QA alkyl chain length and NO release capability
on the bactericidal efficacy against Gram-positive Staphylococcus aureus and Gram-
negative Pseudomonas aeruginosa.
MATERIALS AND METHODS
Tetramethoxysilane and N-(6-aminohexyl)aminopropyltrimethoxysilane were purchased
from Gelest (Morrisville, PA). Glycidyltrimethylammonium chloride, epichlorohydrin,
dimethylbutylamine, dimethyloctylamine, dimethyldodecylamine, trimethylsilanolate,
propidium iodide (PI), and benzalkonium chloride (BAC) were purchased from Sigma
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Aldrich (St. Louis, MO). N,N-dimethylacetamide, methanol (anhydrous), ethanol, ammonia
solution (30%) and tetrahydrofuran (anhydrous) were purchased from Fisher Scientific (Fair
Lawn, NJ). Media and reagents for bacteria and mammalian cell assays were purchased
from Becton, Dickinson and Company (Sparks, MD). Pseudomonas aeruginosa (P.
aeruginosa) (ATCC #19143) and Staphylococcus aureus (S. aureus) (ATCC #29213) were
obtained from American Type Tissue Culture Collection (Manassas, VA), and L929 mouse
fibroblasts were obtained from the UNC Tissue Culture Facility (Chapel Hill, NC). 4,5-
Diaminofluorescein diacetate (DAF-2 DA) was purchased from Calbiochem (San Diego,
CA). Nitrogen (N2), argon (Ar), and nitric oxide calibration (26.81 PPM, balance N2) gases
were purchased from National Welders (Raleigh, NC). Pure nitric oxide gas (99.5%) used
for N-diazeniumdiolate formation was purchased from Praxair (Sanford, NC). Distilled
water was purified using a Millipore Milli-Q UV Gradient A-10 system (Bedford, MA),
resulting in a total organic content of ≤6 ppb and a final resistivity of 18.2 mΩ·cm.
Synthesis of Amine-functionalized Silica Nanoparticles
The Stöber method was used to form monodisperse, spherical silica nanoparticles with
amine functionalities throughout the particle as previously described.29 Briefly, a premixed
solution of N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP) (1.173 mL) and
tetramethoxysilane (TMOS) (0.708 mL) was added to a solution of ethanol (59.16 mL),
water (27.84 mL), and ammonium hydroxide (9.8 mL). The reaction was stirred at room
temperature for 2 h. The resulting white particle precipitates were collected by
centrifugation (3645g, 10 min, 4 °C) and washed thrice with ethanol to remove unreacted
reagents. The particles were then dried in vacuo and stored in a sealed container at room
temperature until further use.
Synthesis of Quaternary Ammonium-functionalized Silica Nanoparticles
The addition of QA functionalities to the particle surface involved the synthesis of
quaternary ammonium epoxides (QA-epoxides) that were then subsequently reacted with
primary amines on the particle via a ring-opening reaction (Scheme 1). To form the QA-
epoxides, 0.04 mmol epichlorohydrin was reacted with 0.01 mmol N,N-dimethylbutylamine,
N,N-dimethyloctylamine, or N,N-dimethyldodecylamine at room temperature overnight.
The mixture was added dropwise to cold ether while sonicating, and the solid/viscous liquid
QA-epoxides were collected via centrifugation (810g, 5 min). The supernatant containing
excess epichlorohydrin and unreacted trialkylamines was decanted, 50 mL fresh cold ether
was added, and the QA-epoxides were sonicated extensively. This washing procedure was
repeated three times, followed by drying of the QA-epoxides in vacuo. The removal of
unreacted epichlorohydrin and trialkylamines was confirmed with 1H NMR.
Glycidyldimethylbutylammonium chloride (butylQA) was a viscous liquid: 1H NMR δ 0.98
(t, 3 H), 1.41 (m, 2H), 1.70 (m, 2H), 2.79 (dd, 1H), 2.98 (t, 1H), 3.24 (dd, 1H), 3.44 (s, 6H),
3.52 ppm (m, 1H), 3.63 ppm (dt, 2H), and 4.62 ppm (dd, 1H); 13C NMR δ 13.8, 19.9, 25.5,
45.5, 45.3, 53.1, 65.4, and 66.9 ppm; ESI/MS m/z 158.09. Glycidyldimethyloctylammonium
chloride (octylQA) was a tacky solid; 1H NMR δ 0.87 (t, 3 H), 1.29 (m, 10 H) 1.71 (m, 2H),
2.74 (dd, 1H), 2.98 (t, 1H), 3.10 (dd, 1H), 3.49 (s, 6H), 3.54 (m, 1H), 3.67 (dt, 2H), and 4.96
ppm (dd, 1H); 13C NMR δ 14.2, 22.9, 23.71, 26.6, 29.4, 32.02, 45.3, 45.5, 53.1, 65.8 and
66.9 ppm; ESI/MS m/z 214.16. Glycidyldimethyldodecylammonium chloride (dodecylQA)
was a waxy solid; 1H NMR δ 0.87 (t, 3 H), 1.27 ppm (m, 18H), 1.70 ppm (m, 2H), 2.74 ppm
(dd, 1H), 2.98 ppm (t, 1H), 3.08 ppm (dd, 1H), 3.54 ppm (s, 6H), 3.58 ppm (m, 1H), 3.65
(dt, 2H), and 4.97 ppm (dd, 1H); 13C NMR δ 14.2, 23.1, 23.7, 26.5, 29.5, 29.7, 29.8, 29.9,
32.38, 45.3, 45.5, 53.1, 65.4, and 66.9 ppm; ESI/MS m/z 270.25. The IR spectra were
similar for all QA-epoxides with the exception of the intensity of the saturated C-H
absorbance at 2919 and 2850 cm−1, which increased with increasing alkyl chain length. IR
(neat): 3019 cm−1 (methyl C-H), 2920 cm−1 (saturated C-H), 2850 cm−1 (saturated C-H),
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1468 cm−1 (methyl C-H), 1267 cm−1 (epoxy ring), 972 (quaternary ammonium), 909 cm−1
(epoxy ring).
A ring opening reaction was subsequently performed between the QA-epoxides and the
primary amines on the surface of the particles (Scheme 1). The amine-containing silica
particles (AHAP, 100 mg) were suspended in 2.5 mL N,N-dimethylacetamide via
sonication, and 20 μL triethylamine was added. The QA-epoxides were dissolved in 5 mL
N,N-dimethylacetamide and added in excess to the particle suspension. Dissolution of
glycidyltrimethylammonium chloride required heating while all other QA-epoxides
dissolved readily. The reaction was heated to 110 °C and allowed to proceed overnight. The
resulting QA-modified particles were collected via centrifugation (3645g, 10 min, 4 °C),
washed thrice with ethanol and dried in vacuo.
N-Diazeniumdiolation of Silica Nanoparticles
Silica particles were loaded with NO by forming N-diazeniumdiolate NO donors on
secondary amine sites (Scheme 2). Briefly, 20 mg of AHAP/TMOS or QA-modified AHAP/
TMOS particles were suspended by sonication in 4 mL of tetrahydrofuran, and
trimethylsilanolate was added in a 3.5-fold excess relative to secondary amines, as
determined with elemental analysis.30, 31 The particle suspensions were then placed in a 160
mL Parr general purpose stainless steel pressure vessel with magnetic stirring and connected
to an in-house NO reactor. The solutions were flushed 6 times with Ar to remove oxygen
from the system, then pressurized to 10 bar with NO that had been scrubbed with KOH. The
pressure was maintained at 10 bar for 3 d, after which it was released and the solutions were
again purged with Ar to remove unreacted NO. The resulting N-diazeniumdiolate-modified
silica nanoparticles were collected by centrifugation (3645g, 10 min, 4 °C), washed twice
with a 50:50 (v/v) mixture of 5 mM NaOH and methanol to remove unreacted base and
byproducts from the particle suspension. The NO-loaded particles were then washed twice
with ethanol and dried in vacuo.
Nitric Oxide Release Measurements
Real-time NO release in deoxygenated PBS (pH 7.4) at 37 °C was monitored using Sievers
NOA 280i chemiluminescence NO analyzer (NOA, Boulder, CO) connected to a customized
reaction cell as described previously.32 The absence of nitrite byproducts was confirmed by
ensuring that total NO concentrations measured from both the Griess assay and the NOA
were equal.33 Prior to analysis, the NO analyzer was calibrated with air passed through a
NO zero filter (0 ppm NO) and a 26.39 ppm NO standard gas (balance N2).
Nanoparticle Characterization
The particles’ zeta potentials (i.e., surface charge) were measured using a Malvern Zetasizer
Nano-ZS equipped with a 10 mW HeNe laser (633 nm) and a NIBS® detector at an angle of
173°. All samples were prepared at 0.5 mg/mL concentrations in either 10 mM NaOH, 10
mM phosphate buffer or 1 vol% TSB in 10 mM phosphate buffer, sonicated briefly and
analyzed at 37 °C. Phosphate buffer (non-saline, pH 7.4) was employed for zeta potential
measurements to mimic the media used for bactericidal assays because the high ionic
contents of phosphate buffered saline were found to corrode the folded capillary
electrodes.34 Particle size and morphology were characterized using a Hitachi S-4700
Scanning Electron Microscope (Pleasanton, CA). Carbon, hydrogen and nitrogen content
were determined on a Perkin Elmer CHN/S elemental analyzer operating in CHN mode. X-
ray photoelectron spectroscopy (XPS) analysis was performed on a Kratos Axis Ultra DLD
X-ray Photoelectron Spectrometer with a monochromatic Al Kα X-ray source (150W).
Electrons were collected at an angle of 90 degrees from the sample surface from a 300 × 700
μm area on the sample. The pass energy was set to 20 eV to allow for high resolution
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spectra to be obtained. All spectra were obtained with a step size of 0.1 eV and calibrated to
the C1s peak at 284.6 eV.
Bactericidal Assays
P. aeruginosa and S. aureus were cultured in tryptic soy broth to a concentration of 108
colony forming units per mL (CFU/mL), collected by centrifugation, and resuspended in
PBS or 1% glucose, 0.5% TSB in PBS, respectively. Of note, S. aureus was not viable in
PBS alone after 24 h. Each bacteria was diluted to 106 CFU/mL and treated with the
appropriate concentration of QA-modified, NO-releasing, or NO-releasing QA-
functionalized silica nanoparticles or BAC. Untreated controls (blanks) were included in
each MBC experiment to ensure untreated bacteria remained viable (at 106 CFU/mL) over
the 24 h incubation period. The samples were briefly sonicated and vortexed in order to
suspend the particles. After 24 h of incubating at 37 °C, the particle-treated bacteria were
spiral plated at 10- and 100-fold dilutions on tryptic soy agar plates. Bacterial viability was
assessed by counting the number of colonies formed on the agar plate using a Flash & Go
colony counter (IUL, Farmingdale, NY). Minimum bactericidal concentrations (MBC) were
determined to be the minimum concentration of particles or BAC that reduced the bacteria
colony counts from 106 to 103 CFU/mL (i.e., 3-log reduction). The plate counting method
used herein has an inherent limit of detection of 2.5×103 CFU/mL.35
Confocal Microscopy for Detection of Intracellular NO and Cell Death
S. aureus was cultured in TSB to a concentration of 1 × 108 cfu/mL, collected via
centrifugation (3645g, 10 min), resuspended in sterile PBS, and adjusted to 1 × 106 cfu/mL
in PBS supplemented with 10 μM DAF-2 DA and 30 μM PI. Aliquots of the S. aureus
solution were incubated in a glass bottom confocal dish for 45 min at 37 °C. A Zeiss 510
Meta inverted laser scanning confocal microscope with a 488 nm Ar excitation laser (2.0%)
and a BP 505–530 nm filter was used to obtain DAF-2 (green) fluorescence images. A 543
nm HeNe excitation laser (25.3%) with a BP 560–615 nm filter was used to obtain PI (red)
fluorescence images. The bright field and fluorescence images were collected using a N.A.
1.2 C-apochromat water immersion lens with a 40× objective. Suspensions (1.5 mL) of
AHAP/NO (1 mg/mL) or dodecylQA-AHAP/NO (1 mg/mL) particles in PBS
(supplemented with 10 μM DAF-2 DA, 30 μM PI) were sonicated and immediately added
to the S. aureus solution (1.5 mL) in the glass confocal dish. Images were collected every 5
min to observe intracellular NO concentrations and bacteria cell death.
In Vitro Cytotoxicity
L929 mouse fibroblasts were grown in DMEM supplemented with 10% (v/v) fetal bovine
serum (FBS) and 1 wt% penicillin/streptomycin, and incubated in 5% (v/v) CO2 under
humidified conditions at 37 °C. After reaching 80% confluency, the cells were trypsinized,
seeded onto tissue culture treated polystyrene 96-well plates at a density of 3×104 cells/mL
and incubated at 37 °C for 48 h. The supernatant was then aspirated and replaced with 200
μL fresh DMEM and 50 μL of either control (AHAP, methylQA, butylQA, octylQA,
dodecylQA) or NO-releasing (AHAP/NO, methylQA/NO, butylQA/NO, octylQA /NO,
dodecylQA/NO) nanoparticle suspensions in PBS at the determined MBCs against P.
aeruginosa or S. aureus. After incubation at 37 °C for 24 h, the supernatant was aspirated
and 120 μL mixture of DMEM/MTS/PMS (105/20/1, v/v/v) was added to each well. After
1.5 h incubation at 37 °C, the solution in each well was transferred to a microcentrifuge tube
and centrifuged for 2 minutes to remove the silica particles. Ninety microliters (90 μL) of
the supernatant was then added to a clean microtiter plate, and the absorbance of the colored
solutions was quantified at 490 nm using a Thermoscientific Multiskan EX plate reader. The
mixture of DMEM/MTS/PMS and untreated cells were used as blank and control,
respectively. The cell viability was calculated by taking the ratio of the absorbance of treated
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cells to the absorbance of untreated cells after subtracting the absorbance of the blank from
both.
RESULTS AND DISCUSSION
Nanoparticle Synthesis and Characterization
We have previously reported the synthesis of amine-functionalized silica particles capable of
variable NO storage and release characteristics.22, 28, 36 For this study, particles were
synthesized by hydrolyzing and co-condensing N-(6-
aminohexyl)aminopropyltrimethoxysilane (AHAP) and tetramethoxysilane (TMOS) via a
modified Stöber process. N-(6-aminohexyl)aminopropyltrimethoxysilane was selected as the
NO-donor precursor due to its suitability for tethering QA-functionalities via primary
amines. The AHAP particles employed in this study were characterized by a spherical
morphology and diameters of 180±26 nm as determined by scanning electron microscopy
(Figure 1A). Dynamic light scattering (DLS) analysis indicated that the particles were
monodisperse with a polydispersity index (PDI) of 0.07±0.02 and a measured Z-average
(190±7 nm), consistent with diameters observed with SEM. Employing a monodisperse
particle system is important for studying antimicrobial efficacy as particle size has been
shown to impact bactericidal activity.22
The AHAP silica particles were modified with QA functionalities via a ring-opening
reaction between surface primary amines and QA-epoxides (Scheme 1). While
glycidyltrimethylammonium chloride is commercially available, earlier work demonstrated
optimal bactericidal efficacy with long chain QAs.9, 37, 38 Quaternary ammonium-epoxides
containing longer alkyl chains were thus synthesized by reacting epichlorohydrin with
dimethylbutylamine, dimethyloctylamine, or dimethyldodecylamine (Scheme 1). The
formation of the QA epoxides was confirmed with 1H and 13C NMR, IR spectroscopy, and
ESI mass spectrometry (Supporting Information). A shift in the 1H NMR resonances
corresponding to the protons alpha to Cl/N and those of the nitrogen bound methyl groups
confirmed the formation of the QA epoxide. Infrared absorbance bands indicating the QA-
epoxide structure were also observed at 970 cm−1 (QA),39 1267 cm−1 (epoxide ring), and at
2920 and 2850 cm−1 (saturated CH). The intensity of the saturated CH absorbance increased
with the increase in the length of the alkyl chain.
The addition of QA groups to the particle surface was confirmed by monitoring changes in
the nitrogen environments (N 1s) using X-ray photoelectron spectroscopy (XPS). As shown
in Figure 2A, the N 1s peak for unmodified AHAP particles was fit with two component
peaks at binding energies of 399 and 400 eV, corresponding to primary and secondary
amines, respectively. The N 1s peak of QA-functionalized particles consisted of a third
component at 402 eV, representing the quaternary ammonium (Figure 2B–E).40 The R4N+
peak was most intense for the methylQA modified particles. The presence of a peak at 399
eV for all QA-functionalized particles indicates that not all primary amines at the particle
surface were functionalized. Of note, a doublet at 198 eV was also observed for the QA-
functionalized particles (Supporting Information), signifying the presence of the chloride
counter ion. As expected, the synthetic strategy for QA surface modification did not
influence particle size or morphology (Figure 1B–E).
Quaternary ammonium functionalization was also verified by observing changes in the zeta
potentials between AHAP and QA-modified AHAP particles using laser doppler
velocimetry (LDV). In 10 mM phosphate buffer PB, both unmodified AHAP and QA-
modified particles exhibited a positive zeta potential due to the presence of protonated
primary amines or positively charged QAs, respectively. In contrast, the zeta potential for
the unmodified AHAP particles became negative in basic media (10 mM NaOH), whereas
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the QA-functionalized particles remained positively charged (Table 1), indicating the
presence of a permanent, pH independent positive charge. A slight decrease in the zeta
potential for longer chained QA-modified particles was observed with increasing pH, which
was also accompanied by a decrease in the derived count rates. Since all samples were
prepared at the same concentration using similarly sized particles, the decrease in the
derived count rate indicates sedimenting particles,41 an expected phenomenon for more
hydrophobic particles. Of note, the derived count rate and zeta potential of methylQA
particles did not change regardless of pH. Overall, the larger count rates for the QA-
modified particles in 10 mM NaOH suggest the positively charged particles are more
stabilized in basic solution due to an abundance of negatively charged ions supporting the
Stern layer.41
Nitric Oxide Release Analysis
The silica particles were exposed to high pressures of NO in the presence of a base to form
N-diazeniumdiolates NO donors (i.e., NONOates) on the secondary amines. As shown in
Figure 2, NONOate formation was confirmed by an absorbance maximum at 253 nm.20
Figure 2 also depicts the absorbance from non-NO-releasing dodecyl-QA-modified AHAP,
indicating the absence of the peak at 253 nm prior to exposure to NO. Of note, no
absorbance maximum is present at 450 nm following exposure to NO, indicating the
particles are free of cytotoxic nitrosamines.42
Nitric oxide storage and delivery was evaluated by monitoring NO production in real time
via chemiluminescence. The addition of QA-functionalities did not influence the amine to
NONOate conversion as each system released similar NO payloads of ca. 0.3 μmol/mg
(Table 2). As such, the role of QA alkyl chain length on bactericidal efficacy could be
elucidated since NO release remained constant. The Griess assay was used to confirm that
no nitrite was formed during the NONOate reaction and NO liberation.33 As is typical for
NONOate-based silica particles,28, 36 the real-time NO release profiles exhibited a
maximum instantaneous NO concentration ([NO]max) that was achieved shortly after the
particles were introduced into the solution. The unmodified AHAP/NO and methylQA/NO
were characterized as having similar [NO]max values (1388±161 and 1034±32 ppb/mg,
respectively), whereas butylQA/NO, octylQA/NO, and dodecyl/NO had lower [NO]max
(882±36, 791±52, 617±68 ppb/mg, respectively). The decrease in [NO]max with increasing
alkyl chain may be attributed to the increased surface hydrophobicity that slows the rate of
water diffusion into the particle. Such behavior was further demonstrated by an increase in
the time to reach [NO]max (i.e., tmax) with increasing QA alkyl chain length. The NO
payloads for each particle system were completely depleted by 24 h.
Bactericidal Efficacy
S. aureus and P. aeruginosa are two of the most commonly isolated species in chronic
wounds and were therefore selected as the test microbes to evaluate the efficacy of the QA-
functionalized nanoparticles presented herein.43 We sought to test our nanoparticles against
both Gram-positive (S. aureus) and Gram-negative (P. aeruginosa) bacteria strains as
previous work has shown that the potency of both NO- and QA-based antimicrobials depend
greatly on the bacterial membrane composition.14, 44 Prior to evaluating the bactericidal
activity of the dually functional nanoparticles, the efficacy of the monofunctional
formulations alone (i.e., NO-releasig or QA-functionalized) were evaluated to fully
understand the benefit of designing a combination approach.
The AHAP/NO particles proved to be significantly more effective against P. aeruginosa
compared to S. aureus with MBC24h of 1.5 and 3.5 mg/mL, respectively (Figure 4). These
results are consistent with previously reported N-diazeniumdiolate based NO-releasing
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nanoparticles.21 Conversely, the antimicrobial activity of the QA-functionalized particles
was greater against S. aureus than P. aeruginosa (Figure 4). Chen et al. also reported greater
sensitivity of Gram-positive bacteria to QA-based antimicrobials compared to Gram-
negative bacteria.14 As shown in Figure 4, the methylQA particles did not present
appreciable toxicity to either of the microbes tested. As expected, the bactericidal efficacy of
QA-modified particles exhibited a strong dependence on alkyl chain length. Increasing the
alkyl chain length from methyl to butyl, octyl and dodecyl resulted in a decrease in MBC24h
from 4.0, 3.0 and 1.5 mg/mL against S. aureus, respectively. OctylQA and dodecylQA
particles were equally effective against P. aeruginosa and more effective than the butylQA
particles. Antimicrobial activity of short chained QAs results from the positively charged
ammonium group complexing with the negatively charged bacterial cell membrane to
disrupt membrane functions, alter the balance of essential ions (i.e., K+, Na+, Ca2+, and
Mg2+), interrupt protein activity, and damage bacterial DNA.45 Long alkyl chain QAs can
exert additional antimicrobial activity by inserting into the bacterial membrane, resulting in
physical disruption.45 Indeed, longer alkyl chains have been shown to be more effective due
to deeper penetration into the membrane and concomitant disruption.9, 37, 38 As a positive
control, the bactericidal efficacy of benzalkonium chloride (BAC), a QA salt, was also
determined under the assay conditions used herein. Benzalkonium chloride was chosen as a
control as it is a long chained QA salt used as a commercial antiseptic. The MBC24h doses
of BAC against S. aureus and P. aeruginosa were 4 and 16 μg/mL, respectively. The lower
doses of BAC required to induce a 3 log reduction compared to QA-modified particles are
attributed to the macromolecular structure having an inherently larger mass due to the silica
backbone. Moreover, the immobilization of the QAs onto the particle surface suggests their
antimicrobial mechanisms differ from those of long chain QA salts that readily diffuse
through cell membranes. The mechanism of action of QAs tethered to polymer surfaces has
been proposed to depend strongly on the disruption of electrolyte equilibrium and less
strongly on alkyl chain length.11 However, the structure-dependent antimicrobial activity of
the QA particles presented here suggests their antimicrobial mechanism may involve
penetration into the cell membrane. OctylQA and dodecylQA particles were characterized
by a negative zeta potential in 1 vol% TSB in PBS due to the likely adhesion of proteins to
the particle surface (Supporting Information). These results indicate that the positive charge
of the QA functionalities plays less of a role in their bactericidal activity.
The advantages of combining antimicrobial strategies on the same particle have previously
been demonstrated with QA-functionalized surfaces that release an antimicrobial agent, such
as silver ion7, 17 or gentamicin.18 Although these releasable therapies are potent
antimicrobials, resistance concerns plaque their wide-spread use.46, 47 The QA-
functionalized particles described herein were designed to allow for the release of NO, a
broad-spectrum antimicrobial with low risk of resistance.25 As shown in Figure 4, NO-
releasing long chain (i.e., octyl and dodecyl) QA-functionalized particles exhibited increased
toxicity against S. aureus compared to particles functionalized with short chain (i.e., methyl
or butyl) QAs or NO release alone. Nitric oxide-releasing AHAP/NO, methylQA/NO, and
butylQA/NO were equally effective against S. aureus with an MBC24h of 3.5 mg/mL.
Increasing the alkyl chain length of NO-releasing QA particles to octyl and dodecyl
improved the antimicrobial activity with a substantial decrease in MBC24h to 1.5 and 1.0
mg/mL, respectively. Disruption of the bacterial membrane by the long chain QAs may
allow for greater oxidative stress due to increased intracellular NO levels compared to
treatment with AHAP/NO.44 The combination of NO release and QA modification (i.e.,
NO-releasing QA-functionalized particles) did not alter the antimicrobial efficacy against P.
aeruginosa compared to unfunctionalized NO-releasing particles (i.e., AHAP/NO). These
results reflect those of the monofunctional particles, where the MBC24h of dodecylQA was
much greater than that of AHAP/NO against P. aeruginosa.
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To prove the advantage of co treatment with QA-functionalized NO-releasing particles, we
treated S. aureus and P. aeruginosa to 25% of the MBC24h values of dodecylQA and AHAP/
NO either simultaneous or at 30 min intervals. Sublethal doses were used to avoid complete
killing and allow for viable enumeration, and short exposure intervals were used to inhibit
the production of new or repaired cells.44 As shown in Figure 5, the simultaneous addition
of the two separate antimicrobial particles resulted in greater antimicrobial action against S.
aureus than when the microbes were exposed to one agent (e.g., AHAP/NO or dodecylQA)
followed by the second 30 min later. In comparison, the decrease in P. aeruginosa viability
was the same for all combination treatments regardless of the addition order. These latter
results were not surprising as the antimicrobial activity of NO-releasing dodecylQA was
equal to that of NO-releasing AHAP/NO against P. aeruginosa.
Confocal microscopy was used to study the antimicrobial mechanisms of NO-releasing
dodecylQA/NO particles against S. aureus. DAF-2, a green fluorescent marker for
intracellular NO, and PI, a red fluorescent marker for a compromised membrane, were used
to visualize the effects of the NO-release particles on the bacteria. As shown in Figure 7,
treatment with dodecylQA/NO resulted in red fluorescence and weak green fluorescence
after 60 min. Conversely, treatment with AHAP/NO for the same time period resulted in
strong green fluorescence due to DAF without the presence of red fluorescence. Thus, the
QA-functionalities were observed to cause membrane disruption, even before significant
intracellular NO concentrations were achieved. As expected, the intensity of the green
fluorescence increased with incubation time, indicating elevation of the intracellular NO
concentrations. Moreover, the faster release kinetics of AHAP/NO compared to dodecylQA/
NO resulted in greater intracellular NO concentrations at shorter exposure times.
Small differences in the physical and chemical properties of nanomaterials have been shown
to greatly influence nanoparticle-cell interactions,48 suggesting that the use of dual function
nanoparticles may be more favorable than co-administering two different monofunctional
nanoparticles. To investigate the validity of this hypothesis, the MBC24h of a mixture of
dodecylQA and AHAP/NO (50:50 w/w) particles was also determined. The MBC24h of the
dodecylQA+AHAP/NO particle mixture was 2.0 and 3.0 mg/mL against S. aureus and P.
aeruginosa, respectively. The NO and QA concentrations of the 50:50 dodecylQA+AHAP/
NO mixture correspond to the same NO and QA concentrations delivered from the MBC24h
doses of dodecylQA/NO (i.e., 1.0 and 1.5 mg/mL, respectively). Thus, combining NO
release and QA-functionalities on the same particle proved advantageous as a lower total
dose of particles was required to induce bactericidal efficacy compared to treatment with a
mixture of two monofunctional particles.
In Vitro Cytotoxicity
The ultimate utility of next generation antimicrobials is often governed by their toxicity to
mammalian cells, assuming adequate microbial killing. Although long chain quaternary
ammonium salts have long been used clinically, they are mostly restricted to topical
applications due to their toxicity against mammalian cells.38, 49 However, tethering QAs to a
macromolecules has been shown to decrease their toxicity toward eukaryotic cells.49 We
thus evaluated the toxicity of QA- and NO-releasing QA-functionalized particles against
L929 fibroblasts cells (Figure 7). Fibroblast cells represent the standard for cytotoxicity
screening of new antimicrobials due to their involvement in wound healing and the immune
response.50, 51 The viability of fibroblasts cells was monitored via the MTS assay following
24 h exposure to the MBC24h against both S. aureus and P. aeruginosa. Control AHAP
particles exhibited significant toxicity at the high particle dose of 6.0 mg/mL due to the
presence of primary amines.21, 52 Conversion of the primary amines to trimethylQA groups
caused a significant decrease in the observed cytotoxicity, as 8 mg/mL of methylQA
particles only decreased viability by 40%. The cytotoxicity of QA-functionalized particles
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against fibroblasts at their MBC increased with increasing alkyl chain length. For example,
4.0 mg/mL butylQA, octylQA or dodecylQA-modified particles resulted in a 45, 60, and
94% decrease in viability, respectively. Fibroblast viability was decreased by 21 and 86%
upon treatment with 4 and 16 μg/mL BAC. The cytotoxic effects observed even at
significantly lower BAC concentrations indicate the advantage of particle bound QAs.
Due to the lower concentrations of particles required for microbial killing with NO-release,
the cytotoxicity of NO-releasing QA-particles against fibroblast was notably less. For
example, 4.0 mg/mL dodecylQA (MBC24h against P. aeruginosa) resulted in a 94% decrease
in fibroblast viability, while the MBC24h dose of dodecylQA/NO (1.5 mg/mL) decreased
fibroblast viability by only 69%. Moreover, the cytotoxicity of dodecylQA/NO was lower
than that of BAC alone at the P. aeruginosa MBC. These results indicate that although no
synergistic effects were observed for the dodecylQA/NO system, the coupling of QA-
functionalities and NO release on the same particle may be advantageous as lower doses
(particle concentrations) could be used to achieve bactericidal activity with less impact to
mammalian cells.
CONCLUSIONS
Quaternary ammonium (QA)-functionalized particles exhibited antimicrobial action against
both S. aureus and P. aeruginosa, with long alkyl-chain QAs (e.g., octyl and dodecyl)
proving more potent than short alkyl-chain QAs (e.g., methyl and butyl). The
functionalization of particles with both QA groups and NO donors resulted in particles with
even more favorable antimicrobial activity against S. aureus compared to monofunctional
QA-functionalized or NO-releasing particles alone. Conversely, the antimicrobial activity of
the hybrid particles against P. aeruginosa was unchanged relative to the NO-releasing only
particles. Overall, S. aureus was more sensitive to QA particle treatment, while the inverse
was true for P. aeruginosa (greater sensitivity to NO). In addition, hybrid NO release/QA-
functionalized particles proved to be more effective at microbial killing than mixtures of
NO-releasing and QA-functionalized particles. The design of materials expressing multiple
antimicrobial mechanisms of action may represent an important strategy for lowering the
concentration of therapy required and reducing the risk of potential resistance.
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Refer to Web version on PubMed Central for supplementary material.
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Scanning electron micrographs of (A) AHAP (d=180±26 nm), (B) methylQA (d=181±27
nm), (C) butylQA (d=187±23 nm), (D) octylQA (d=185±26 nm), and (E) dodecylQA
(d=187±24 nm) nanoparticles. Scale bar = 500 nm.
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X-ray photoelectron (XPS) spectra of the N 1s peak of (A) AHAP, (B) methylQA, (C)
butylQA, (D) octylQA, and (E) dodecylQA nanoparticles. The presence of primary (blue),
secondary (green) and quaternary (red) amines are indicated by fitted curves at binding
energies of 399, 401, and 402 eV, respectively.
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UV-Vis absorbance spectra of N-diazeniumdiolate-modified AHAP and QA silica
nanoparticles. Unmodified dodecylQA is shown for comparison.
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Minimum bactericidal concentrations (MBC24h) against (A) S. aureus and (B) P. aeruginosa
for non-NO-releasing (solid) and NO-releasing (hashed) AHAP (red), methylQA (green),
butylQA (blue), octylQA (magenta), dodecylQA (cyan). Treatment with a 50:50 (w/w)
mixture of dodecylQA and AHAP/NO particles is shown in yellow (hashed).
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Change in bacterial viability of (A) S. aureus and (B) P. aeruginosa following exposure to
sublethal doses of dodecylQA and/or AHAP/NO nanoparticles either simultaneously or at
30 min intervals.
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Confocal microscopy images of S. aureus exposed to (A) dodecylQA/NO and (B) AHAP/
NO particles exhibit green fluorescence due to intracellular NO (DAF) and red fluorescence
due to compromised membrane (PI). Scale bar = 1 μm.
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Percent viability of L929 mouse fibroblasts cells following 24 h exposure to non-NO-
releasing (solid) and NO-releasing (hashed) AHAP (red), methylQA (green), butylQA
(blue), octylQA (magenta), and dodecylQA (cyan) particles compared to control (untreated)
cells with the numbers corresponding to the MBC24h against S. aureus and P. aeruginosa (in
mg/mL dose).
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Quaternary ammonium (QA) epoxides were synthesized via reaction of epichlorohydrin
with a dimethylalkylamine and subsequently reacted with the primary amines on the surface
of AHAP/TMOS particles to yield QA-functionalized silica nanoparticles.
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N-Diazeniumdiolate NO donors were formed on secondary amines within the particle upon
exposure to high pressures of NO in the presence of a base (e.g., NaOSiMe3). In the
presence of a proton source (e.g., H2O), these NO donors breakdown to regenerate the
parent amine and two molecules of NO.
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Table 1
Zeta potential measured from AHAP and QA-modified AHAP particle solutions.
Zeta Potential
(mV)
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Table 2
Nitric oxide release properties of unmodified and QA-modified silica nanoparticles, including total NO release







AHAP/NO 0.27±0.04 1388±161 1.5±0.2
MethylQA/NO 0.30±0.03 1034±32 1.8±0.3
ButylQA/NO 0.27±0.03 882±36 2.3±0.2
OctylQA/NO 0.28±0.04 791±52 2.9±0.6
DodecylQA/NO 0.27±0.04 617±68 4.3±0.8
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